Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting type 1 diabetes.

Peter Achenbach1, Ezio Bonifacio, Anette-G Ziegler

  • 1Diabetes Research Institute, Koelner Platz 1, Munich 80804, Germany.

Current Diabetes Reports
|March 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determinants of Infant Participation and Non-Participation in Primary Prevention Trials.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026
Same author

Retinol, Carotenoid, and Tocopherol Intake and Status, and the Risk of Islet Autoimmunity and Type 1 Diabetes: The Environmental Determinants of Diabetes in the Young Study.

Diabetes/metabolism research and reviews·2026
Same author

Integrated transcriptomic and TCR profiling reveals local immune dysregulation of T cells in Gl aGvHD.

Bone marrow transplantation·2026
Same author

Screening Children for Early-Stage Type 1 Diabetes.

JAMA·2026
Same author

Psychosocial implications, acceptability and ethics of screening for paediatric type 1 diabetes: a systematic review and mixed methods evidence synthesis.

Diabetologia·2026
Same author

Health Care Provider Perceptions of Screening for Early-Stage Type 1 Diabetes-A Survey Study.

Diabetes, obesity & metabolism·2026
Same journal

Continuous Glucose Monitoring in Type 2 Diabetes: Clinical Outcomes, Disparities in Access, and Cost-effectiveness.

Current diabetes reports·2026
Same journal

Beyond Inflammation - A Multidisciplinary Approach to Managing Obesity and Cardiometabolic Risk in Inflammatory Bowel Disease.

Current diabetes reports·2026
Same journal

Climate Change and Diabetes Outcomes: Evidence from Climate-Vulnerable Regions.

Current diabetes reports·2026
Same journal

Efficacy and safety of once-weekly basal insulin analogs versus daily basal insulin analogs in adults with type 2 diabetes: a systematic review and meta-analysis.

Current diabetes reports·2026
Same journal

Use of Glucagon-Like Peptide-1 Receptor Agonists in Women with Type 2 Diabetes Before Pregnancy: Addressing the Dilemma in A Real-World Setting.

Current diabetes reports·2026
Same journal

Can Behavioral Interventions Promote Health Equity in Pediatric Type 1 Diabetes? A Narrative Review of Promising Treatments.

Current diabetes reports·2026
See all related articles

Predicting type 1 diabetes mellitus (T1DM) involves assessing genetic risk, autoantibodies, and metabolic changes. Early prediction using these markers aids in disease prevention and intervention strategies.

Area of Science:

  • Endocrinology
  • Immunology
  • Genetics

Background:

  • Type 1 diabetes mellitus (T1DM) prediction is crucial for effective prevention strategies.
  • Current prediction involves genetic susceptibility, autoantibody detection, and metabolic staging.
  • Stratifying risk aids in selecting individuals for primary intervention trials.

Purpose of the Study:

  • To outline the multi-level approach for predicting type 1 diabetes mellitus.
  • To highlight the utility of genetic markers, autoantibodies, and metabolic tests in risk stratification.
  • To emphasize the importance of early prediction for disease prevention.

Main Methods:

  • Assessing genetic markers including HLA and INS genotypes.
  • Measuring circulating islet autoantibodies in at-risk individuals.

Related Experiment Videos

  • Utilizing metabolic tests to stage preclinical disease (prediabetes).

    • Main Results:

    • Combinations of genetic markers and family history can stratify T1DM risk over 1000-fold.
    • Autoantibody measurements identify individuals who will develop T1DM.
    • Autoantibody characteristics refine risk stratification in positive subjects.

    Conclusions:

    • Multi-level prediction, integrating genetic, immunological, and metabolic factors, is feasible.
    • Early identification of T1DM risk enables targeted primary prevention efforts.
    • Stratified risk assessment optimizes selection for intervention trials.